Summary
Objective
To determine whether intravenous infusion of either human albumin or hydroxyethylstarch (HES) in hypo-albuminemic critically ill may lead to an increase in colloid osmotic pressure and to a better clinical outcome, i.e. lower mortality and fewer complications, compared to fluid replacement with normal saline
Design
Prospective, randomized controlled clinical trial during 72 hours in 61 consecutively admitted severely ill patients. Randomisation took place by sealed envelope, kept outside of the hospital.
Setting
Intensive care unit of the Twenteborg Hospital, Almelo, The Netherlands.
Subjects
Sixty-three severely ill, hypo-albuminemic patients were selected; 27 patients had severe sepsis and 36 were post-surgical patients with SIRS. Two patients died shortly after randomization, 15 patients received human albumin, 15 HES 500 and 15 HES 1000 ml, and 16 saline.
Interventions
The patients were randomized to receive 300 ml human albumin (20%) per day, or 1000 ml normal saline per day, or 500 ml or 1000 ml HES per day, all for 72 hours.
Main outcome measures
The primary outcome was plasma colloid osmotic pressure (COP). Secondary end-points were fluid balance and the development of pulmonary edema.
Results
Administration of human albumin was effective in raising COP (P<0.001 on day 2 and day 3, compared to saline and HES). Neither fluid balances nor the development of peripheral or pulmonary edema were different between the groups. Mortality as well as length of stay at ICU were slightly higher in the group receiving human albumin although not statistically significant.
Conclusion
Raising colloid osmotic pressure with human albumin in hypoalbuminemic patients is not associated with improvement of the clinical outcome
Similar content being viewed by others
References
Nielsen OM, Engell HC (1985) Extra-cellular fluid volume and distribution in relation to changes in plasma colloid pressure after major surgery. Acta Chir Scand 151: 221–225
Prien T, Backhaus N, Pelster F, Pircher W, Bunte H, Lawin P (1990) Effect of intraoperative fluid administration and colloid osmotic pressure on the formation of intestinal edema during gastrointestinal surgery. J Clin Anesth 2: 317–323
Camu F, Ivens D, Christiaens F (1995) Human albumin and colloid fluid replacement: their use in general surgery. Acta Anaesth Belg 46: 3–18
Goldwasser P, Felman J (1997) Association of serum albumin and mortality risk. J Clin Epidemiol 50: 693–703
Erstad BL, Gales BJ, Rappaport WD (1991) The use of albumen in clinical practice. Are Intern Med 151: 901–911
Foley EF, Borlase BC, Dzik WH, Bistrian BR, Benotti PN (1990) Albumin supplementation in the critically ill: a prospective randomised trial. Arch Surg 125: 739–742
Golwasser P, Feldman J (1997) Association of serum albumin and mortality risk. J Clin Epidemiol 50: 693–703
Ernest D, Belzberg AS, Dodek PM (1999) Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med 27: 46–50
Task Force of the American College of Critical Care Medicine, Society of Critical Medicine (1999) Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 27: 639–660
Cochrane Injuries Group Albumin Reviewers (1998) Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 317: 29–34
Schierhout G, Roberts I (1998) Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 316: 961–964
Alderson P, Bunn F, Levebre C, et al (2002) Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Review
Vincent JL, Dubois MJ, Navickis RJ, Wilkies MM (2003) Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 237: 319–334
Callagher JD, Moore RA, Kerns D, Jose AB, Botros SB, Flicker S, et al (1985) Effects of colloid or crystalloid administration on pulmonary extravascular water in the postoperative patient after coronary bypass grafting. Anesth Analg 64: 753–758
Rubin H, Carlson DS, De Meo M, Ganger D, Craig R (1997) Randomized, double — blind study of intravenous human albumin in hypoalbuminaemic patients receiving total parenteral nutrition. Crit Care Med 25: 249–252
Pockaj BA, Yang JC, Lotze MT, Lange JR, Spence WF, Steinberg S, et al (1994) A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of vascular leak syndrome associated with interleukine-2-therapy. J Immunother 15: 22–28
Guthrie RD, Hines C Jr (1991) Use of intravenous albumin in the critically ill patient. Am J Gastroent 86: 255–262
Roberts JS, Bratton SL (1998) Colloid volume expanders: problems, pitfalls, and possibilities. Drugs 55: 621–630
Emerson TE Jr (1989) Unique features of albumen: a brief review. Crit Care Med 89: 690–694
Choi PTL, Yip G, Quinonez LG, Cook DJ (1999) Crystalloids versus colloids in fluid resuscitation: a systematic review. Crit Care Med 27: 200–210
Hondebrink Y, Jeekel L, Oude Nijhuis J, Woittiez AJJ (1997) Restoration of colloid osmotic pressure in hypoalbuminaemic patients. Intensive Care Med 23 [Suppl 1]: S138
McClelland B (1998) Albumin: don’t confuse us with the facts. BMJ 317: 3–4
Tonnesen T, Tollofsrud S, Kongsgaard UE, Noddeland H (1997) Colloid osmotic pressure of plasma replacement fluids. Acta Anaesth Scan 37: 424–426
Guidet B, Podevin P, Robert A, Chauvin P, Maury E, Offenstadt G (1997) High doses of hydroxyethyl starch and human albumin have similar effects on monocyte function and oncotic pressure. Eur J Clin Invest 27: 943–947
Hiesmayr M, Druml W (1999) Are there still indications for albumin? Wien Klin Wochenschr 111: 1–4
Boldt J, Mueller M, Mentges D, papsdorf M, Hempelmann G (1998) Volume therapy in the critically ill: is there a difference? Intensive Care Med 24: 28–36
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Veneman, T.F., Nijhuis, J.O. & Woittiez, A.J.J. Human albumin and starch administration in critically ill patients: A prospective randomized clinical trial. Wien Klin Wochenschr 116, 305–309 (2004). https://doi.org/10.1007/BF03040900
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03040900